US Patent Issued to SHANGHAI ARK BIOPHARMACEUTICAL on March 24 for "Synthesis and application of class of respiratory syncytial virus inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,661, issued on March 24, was assigned to SHANGHAI ARK BIOPHARMACEUTICAL Co. LTD. (Shanghai).

"Synthesis and application of class of respiratory syncytial virus inhibitors" was invented by Cheng Peng (Suzhou, China), Xiashi Lv (Suzhou, China), Mengfei Qian (Suzhou, China), Wei Yin (Suzhou, China), Chaojun Gong (Suzhou, China), Jian Han (Suzhou, China), Wei Shen (Suzhou, China), Danbin Li (Suzhou, China), Gang Zou (Suzhou, China), Haiqing Yuan (Suzhou, China) and Zhen Jim Wu (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides the synthesis and application of respiratory syncytial virus inhibitor, being a comp...